demonstrated that leptin‐induced pre‐B‐cell leukemia transcription factor 3 binds to the promoter of FGFR1, thereby activating the FGFR1 pathway and leading to letrozole resistance in tumor cells. This evidence concerns the gene FGFR1 and neoplasm.